In the case of the AD1, the worms were also screened at day 4 to assess whether the antibodies lose efficacy at day 7 as a consequence of degradation, which may be significant in the case of experiments involving a long period between administration and screening.
← all excerpts
Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method.
1
—
—